Drug Shortage Report for ALOXI
Report ID | 163388 |
Drug Identification Number | 02381729 |
Brand name | ALOXI |
Common or Proper name | palonosetron hydrochloride |
Company Name | KNIGHT THERAPEUTICS INC. |
Market Status | DORMANT |
Active Ingredient(s) | PALONOSETRON |
Strength(s) | 0.5MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging size | 1 |
ATC code | A04AA |
ATC description | ANTIEMETICS AND ANTINAUSEANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-06-23 |
Actual start date | 2022-06-23 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2022-08-11 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3400 DE MAISONNEUVE BLVD W MONTREAL, QUEBEC CANADA H3Z 3B8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2022-08-11 | French | Compare |
v6 | 2022-08-11 | English | Compare |
v5 | 2022-07-06 | French | Compare |
v4 | 2022-07-06 | English | Compare |
v3 | 2022-06-24 | English | Compare |
v2 | 2022-06-23 | French | Compare |
v1 | 2022-06-23 | English | Compare |
Showing 1 to 7 of 7